01
Drug combination
EXPOSURE / COMPARISON
Triple Whammy
×
REPORTED EVENT
Acute Kidney Injury
Case framework
03BSAFETY SIGNAL ANALYTICS
Structuring safety questions
for analysis
Each case begins by clearly defining the exposure, comparator, adverse event, and scope. The portfolio is structured to accommodate validated findings as they become available.
PORTFOLIO NOTE
The entries below are analytical topics. They do not present unvalidated estimates or causal conclusions.
02
Drug class
EXPOSURE / COMPARISON
SGLT2 Inhibitors
×
REPORTED EVENT
Diabetic Ketoacidosis
Case framework
03
Comparative signal
EXPOSURE / COMPARISON
DHP Calcium Channel Blockers
×
REPORTED EVENT
Peripheral Edema
Case framework
04
Drug class
EXPOSURE / COMPARISON
Sulfonylureas
×
REPORTED EVENT
Hypoglycemia
Case framework
05
Comparative signal
EXPOSURE / COMPARISON
Vancomycin vs Piperacillin/Tazobactam
×
REPORTED EVENT
DRESS
Case framework
06
Drug combination
EXPOSURE / COMPARISON
Losartan + Spironolactone
×
REPORTED EVENT
Alopecia
Case framework
07
Drug class
EXPOSURE / COMPARISON
Statins
×
REPORTED EVENT
Rhabdomyolysis
Case framework
RX PHARMALOGUE ANALYTICA